Pangrol 25 000

Package Leaflet: Information for the User

Pangrol 10,000,10,000 Ph.Eur. lipase, capsules
(Pancreatinum)

Read the package leaflet carefully before taking the medicine, as it contains important information for the patient.

This medicine should always be taken exactly as described in the patient leaflet or as directed by a doctor or pharmacist.

• Keep this leaflet, you may need to read it again.
• If you need advice or additional information, consult a pharmacist.
• If the patient experiences any side effects, including any possible side effects not listed in the leaflet, they should inform their doctor or pharmacist. See section 4.
• If after 7-14 days there is no improvement or the patient feels worse, they should contact their doctor.

Table of Contents of the Leaflet:

• 1. What is Pangrol 10,000 and what is it used for
• 2. Important information before taking Pangrol 10,000
• 3. How to take Pangrol 10,000
• 4. Possible side effects
• 5. How to store Pangrol 10,000
• 6. Contents of the pack and other information

1. What is Pangrol 10,000 and what is it used for

What is Pangrol 10,000?

Pangrol 10,000 contains digestive enzymes (of porcine origin, powdered pancreas, also known as pancreatin).

What is Pangrol 10,000 used for?

Pangrol 10,000 is used as a supplement to pancreatic enzymes in people with digestive disorders resulting from a lack or insufficient secretion and/or action of pancreatic enzymes in the duodenum. Such disorders may occur, for example, in the following circumstances:

• chronic pancreatitis, regardless of the cause (alcoholic, traumatic, autoimmune, drug-induced, tropical calcification, idiopathic);
• specific pancreatic dysfunction (cystic fibrosis);
• constriction of the pancreatic duct caused by, for example, a tumor or gallstones;
• liver and bile duct disorders;
• previous pancreatic surgery or pancreatectomy and duodenectomy;
• accelerated intestinal passage after stomach and intestinal surgery, due to stress or inflammatory bowel disease;
• consumption of difficult-to-digest plant foods, fats, or foods to which the digestive system is not accustomed, leading to impaired absorption of nutrients and digestive disorders with accompanying loss of appetite, bloating, nausea, and diarrhea (malabsorption);
• intestinal disease;
• inflammatory bowel disease (especially Crohn's disease);
• diabetes;
• acquired immune deficiency syndrome (AIDS);
• Shwachman syndrome;
• Sjögren's syndrome.

The medicine can be used in adults (including the elderly) and children. If after 7-14 days there is no improvement or the patient feels worse, they should contact their doctor.

2. Important information before taking Pangrol 10,000

When not to take Pangrol 10,000

• if the patient is hypersensitive to pancreatin, pork meat, or any of the other ingredients of this medicine (listed in section 6).
• in patients with acute pancreatitis and acute exacerbations of chronic pancreatitis, in the acute phase of the disease.

However, occasional administration of the medicine is appropriate in the phase of subsiding disease, during the expansion of the oral diet (light diet), if symptoms of persistent pancreatic dysfunction occur.

Warnings and precautions

Before starting to take Pangrol 10,000, the patient should discuss it with their doctor or pharmacist:

in case of symptoms indicating intestinal obstruction (e.g., abdominal pain, lack of bowel movements, nausea, vomiting). Intestinal obstruction is a common complication in patients with cystic fibrosis.

as a precaution, any unusual symptoms from the abdomen or stomach and intestines, or changes in existing symptoms, should be examined by a doctor to rule out intestinal damage. This applies especially to patients taking more than 10,000 Ph.Eur. lipase per kilogram of body weight per day. This medicine contains active enzymes that, if released in the mouth, for example, by chewing, can cause damage (ulcers) to the oral mucosa. Therefore, caution should be exercised and the medicine should only be taken whole.

• j. Ph. Eur. lipase per kilogram of body weight per day.

Pangrol 10,000 and other medicines

The patient should tell their doctor or pharmacist about all medicines they are taking, have recently taken, or plan to take.

Taking ready-made medicines containing pancreatic enzymes may reduce the absorption of folic acid, which means that additional folic acid may be necessary.

Taking Pangrol 10,000 at the same time may weaken the effect of oral anti-diabetic medicines: acarbose and miglitol.

Pregnancy and breastfeeding

If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.

There is no experience with the use of Pangrol 10,000 in pregnant women. Only incomplete data from animal studies on the effect on pregnancy, fetal development, childbirth, and postnatal development are available. The potential risk to humans is not known.

If the patient is pregnant or breastfeeding, they should not take Pangrol 10,000 unless, in the doctor's opinion, it is absolutely necessary.

Driving and using machines

Pangrol 10,000 has no influence or negligible influence on the ability to drive and use machines.

3. How to take Pangrol 10,000

This medicine should always be taken exactly as described in the leaflet or as directed by a doctor or pharmacist. In case of doubt, the patient should consult their doctor or pharmacist.

Dosage

The recommended dose is 2-4 capsules of Pangrol 10,000 per meal (corresponding to 20,000-40,000 Ph.Eur. lipase).

The dosage depends on the severity of the digestive disorders. It may be necessary to take higher doses. Increasing the dosage requires prior consultation with a doctor, and its purpose should be to achieve improvement in relation to symptoms (e.g., fatty stools, stomach pain).

The patient should not exceed the daily dose of 15,000-20,000 lipase units per kilogram of body weight.

In cystic fibrosis, Pangrol 10,000 can be used in adults and children with a body weight of 10 kg or more.

Unless the doctor recommends a different dosage, patients with cystic fibrosis with a body weight of 10 kg or more should take 1-2 capsules of Pangrol 10,000 per meal (equivalent to 10,000-20,000 Ph.Eur. lipase per meal). The doctor may decide to increase the dose depending on the patient's weight and severity of symptoms. The patient should not exceed the maximum dose of 15,000-20,000 lipase units per kilogram of body weight per day.

Children and adolescents

The dosage in children is determined by a doctor.

Method of administration

Pangrol 10,000 capsules should be swallowed whole during a meal, with a large amount of water.

Patients who do not want to swallow the capsule whole can open it over a suitable container (e.g., a glass) and swallow the contents whole with a small amount of liquid.

The patient should be careful not to chew the tablets, as this may reduce the effectiveness of the medicine, and the enzymes released in the mouth may cause damage to the oral mucosa. The patient should drink a large amount of fluid (water or juice).

Duration of treatment

The duration of treatment with Pangrol 10,000 is not limited. The length of treatment depends on the course of the disease and is determined by a doctor.

If the patient does not feel better or feels worse, they should contact their doctor.

If the patient feels that the effect of Pangrol 10,000 is too strong or too weak, they should consult their doctor or pharmacist.

Taking a higher dose of Pangrol 10,000 than recommended

In case of taking a higher dose of the medicine than recommended, the patient should drink a large amount of water and consult their doctor.

Taking very high doses of pancreatin, especially in patients with cystic fibrosis, may lead to an increased level of uric acid in the blood (hyperuricemia) and urine (hyperuricosuria).

Missing a dose of Pangrol 10,000

The patient should not take a double dose to make up for a missed dose. They should take the next dose as directed.

Stopping treatment with Pangrol 10,000

In case of premature termination or interruption of treatment with Pangrol 10,000, the patient should expect the symptoms to return. They should contact their doctor.

In case of any further doubts about the use of this medicine, the patient should consult their doctor or pharmacist.

4. Possible side effects

Like all medicines, Pangrol 10,000 can cause side effects, although not everybody gets them.

Important side effects and symptoms to look out for

If any of the following symptoms occur, the patient should stop taking Pangrol 10,000 and consult their doctor immediately. The doctor will decide on further action.

Very rare side effects (may affect up to 1 in 10,000 people)

Diarrhea, abdominal discomfort, stomach pain, nausea, vomiting

Immediate allergic reactions, such as: skin rash, hives, sneezing, tearing, shortness of breath due to bronchospasm, shortness of breath

Allergic reactions from the gastrointestinal tract

In patients with cystic fibrosis, after taking high doses of pancreatin, narrowing of the lower parts of the intestine (in the ileocecal and ascending colon) has been reported. This can lead to intestinal obstruction (see section 2 "Warnings and precautions").

Frequency not known (cannot be estimated from the available data)

In patients with cystic fibrosis, mainly those taking high doses of pancreatin, there may be an increased excretion of uric acid in the urine. Therefore, the uric acid level in the urine of these patients should be monitored to prevent the formation of uric acid stones.

Reporting side effects

If the patient experiences any side effects, including any side effects not listed in the leaflet, they should inform their doctor, pharmacist, or nurse.

Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:

Al. Jerozolimskie 181C, 02-222 Warsaw

Phone: (22) 49-21-301

Fax: (22) 49-21-309

Website: https://smz.ezdrowie.gov.pl

Side effects can also be reported to the marketing authorization holder.

By reporting side effects, it is possible to gather more information on the safety of the medicine.

5. How to store Pangrol 10,000

Keep out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the carton and bottle or blister after the "EXP" symbol. The expiry date refers to the last day of the month stated.

The container should be kept tightly closed.

Storage conditions

Store in a temperature below 25°C.

After opening the bottle, the medicine retains its potency for 6 months.

Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Contents of the pack and other information

What Pangrol 10,000 contains

The active substance is powdered porcine pancreas. One capsule contains enteric-coated mini-tablets containing powdered porcine pancreas with an activity of:

Lipase 10,000 Ph.Eur.

Amylase 9,000 Ph.Eur.

Protease 5,000 Ph.Eur.

Excipients

mini-tablets:

Croscarmellose sodium

Microcrystalline cellulose

Hydrogenated castor oil

Colloidal anhydrous silica

Magnesium stearate

30% aqueous suspension of ethyl acrylate and methacrylic acid copolymer (1:1), type C

Triethyl citrate

Simethicone emulsion 30%

Talc

capsule:

Gelatin

Iron oxide red (E 172)

Quinoline yellow (E 104)

Iron oxide yellow (E 172)

Indigo carmine (E 132)

Titanium dioxide (E 171)

What Pangrol 10,000 looks like and contents of the pack

Pangrol 10,000 is a green and brown capsule. The capsules are filled with enteric-coated mini-tablets.

Packaging: a polypropylene bottle with a polyethylene cap and a desiccant, containing 20 or 50 capsules.

Blisters of aluminum foil (OPA/Al/PVC)/aluminum in a cardboard box. The boxes contain 20 or 50 capsules.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

BERLIN-CHEMIE AG

Glienicker Weg 125

12489 Berlin, Germany

To obtain more detailed information, the patient should contact the representative of the marketing authorization holder:

Berlin-Chemie/Menarini Polska Sp. z o.o.

Tel: (022) 566 21 00

Fax: (022) 566 21 01

Date of last revision of the leaflet: